Five Minute News 12/21/2021: Trump Sues NY AG, Pentagon Addresses Extremism, Boosters For Omicron

The Five-Minute News is a podcast presented by Anthony Davis and produced by Meidas Touch. Each day it summarizes briefly a few of the top global news stories, centering around events in the realms of public health, economy, and politics — condensing all of this into a few short minutes so listeners can quickly bring themselves up-to-date on world events.

Tuesday’s edition addresses Donald Trump’s lawsuit against New York Attorney General Letitia James in response to her office’s investigation of the Trump Org’s financial practices, new guidance from the Pentagon on extremism in the United States, and some hopeful news about the Omicron variant of COVID-19 and the efficacy of a booster shot.

You can view the entire episode below, or catch it on your preferred podcasting app.

New York Attorney General Letitia James has requested that Donald Trump sit for a deposition in the investigation into his business practices, and Trump has responded with a lawsuit, attempting to force an end to the investigation altogether. He claims that the investigation, which has already resulted in indictments, is just a political attack being carried out due to A.G. James’ “personal disdain” for the former president.

See Also

Kyrsten Sinema Formally Censured By AZ Dem Party Over Voting Rights, Increasing Chance of Primary Challenge

The Pentagon has issued new rules prohibiting service members from engaging in extremist activities, nearly a year after some military members were charged with participating in the attack on the United States Capitol Building and Congress within. The Pentagon says that fewer than 100 military members have been involved in substantiated cases of extremism in the past year, but that the number could rise, particularly with the documented rise in domestic extremism, including among veterans.

There’s good news for those concerned about the Omicron variant of COVID-19. Moderna has affirmed that a booster shot of its vaccine increases neutralizing antibodies to a degree — 37 times increase with a half-dose booster and 83 times with a full-dose booster — that should provide ample protection against the variant that is now the dominant form of COVID-19 in the United States. Pfizer reports similarly improved results.